explore -WSS

explore

author：leisure time 2025-10-01 15:30:57 - browse：34

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medical device lobby: We're tired of waiting on Medicare coverage

WSS

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

There’s no way to know how good AI health technologies are

RSV vaccines may be linked to small increased risk of developing GBS

In search for therapies for solid tumors, companies turn to claudin

Peter Marks talks Operation Warp Speed for Rare Diseases

There’s no way to know how good AI health technologies are

explore

explore

entertainment

In age of alternative facts, a scholarly course on calling out crap

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

How one medical school became remarkably diverse

Flu vaccine offering decent levels of protection this winter, new data show

Novavax promises a turnaround & Lilly roils the obesity market

Nick Jonas talks about managing diabetes along with his career

In age of alternative facts, a scholarly course on calling out crap

House looks to weaken Medicare negotiation

The high cost of giving birth even with insurance

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

hotspot

International team creates first chimeric human

AstraZeneca loses challenge to Medicare drug price negotiation

An inside look at PIPEs, biotech's buzzy new financing tool

Wellcome Trust names Røttingen as its new CEO

Researchers CRISPR chickens in bid to protect them from bird flu

Flu vaccine offering decent levels of protection this winter, new data show

leisure time

leisure time

entertainment

leisure time